Cargando…

Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis

BACKGROUND: Irritable bowel syndrome (IBS) is one of the most common functional gastroenterological diseases, affecting 11.2 % of people worldwide. Previous studies have shown that probiotic treatment may benefit IBS patients. However, the effect of probiotics and the appropriate type, dose, and tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yan, Li, Lixiang, Guo, Chuanguo, Mu, Dan, Feng, Bingcheng, Zuo, Xiuli, Li, Yanqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907258/ https://www.ncbi.nlm.nih.gov/pubmed/27296254 http://dx.doi.org/10.1186/s12876-016-0470-z

Ejemplares similares

Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?
por: Park, Moo In
Publicado: (2010)

Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?: Author's Reply
por: Park, Dong Won, et al.
Publicado: (2010)

Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria
por: Miwa, Hiroto
Publicado: (2008)

The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria
por: WANG, AnJiang, et al.
Publicado: (2008)

Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome
por: Lacy, Brian E., et al.
Publicado: (2017)

The Incidence of Irritable Bowel Syndrome in Children Using the Rome III Criteria and the Effect of Trimebutine Treatment
por: Karabulut, Gülcan S, et al.
Publicado: (2013)

The Rome Criteria Divides, Distorts and Dilutes the Prevalence of Irritable Bowel Syndrome
por: Gwee, Kok-Ann, et al.
Publicado: (2010)

The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson’s Disease Patients According to Rome III Diagnostic Criteria
por: Mishima, Takayasu, et al.
Publicado: (2017)

The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III
por: Park, Dong Won, et al.
Publicado: (2010)

Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting
por: El-Salhy, Magdy, et al.
Publicado: (2019)

High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome III and Rome IV criteria
por: Shiha, Mohamed G., et al.
Publicado: (2020)

Direct healthcare costs of Rome IV or Rome III‐defined irritable bowel syndrome in the United Kingdom
por: Goodoory, Vivek C., et al.
Publicado: (2022)

Subtypes and Symptomatology of Irritable Bowel Syndrome in Children and Adolescents: A School-based Survey Using Rome III Criteria
por: Rajindrajith, Shaman, et al.
Publicado: (2012)

Atopic Patients Who Fulfilled Rome III Criteria for Irritable Bowel Syndrome Had Higher Animal Danders Sensitization
por: Siah, Kewin T H, et al.
Publicado: (2020)

Functional Chronic Constipation: Rome III Criteria Versus Rome IV Criteria
por: Russo, Marina, et al.
Publicado: (2019)

Functional Bowel Disorders in Iranian Population using Rome III Criteria
por: Sorouri, Majid, et al.
Publicado: (2010)

Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome
por: Liu, Yi, et al.
Publicado: (2020)

Gender Role in Irritable Bowel Syndrome: A Comparison of Irritable Bowel Syndrome Module (ROME III) Between Male and Female Patients
por: Anbardan, Sanam Javid, et al.
Publicado: (2012)

Prevalence of Organic Colonic Lesions by Colonoscopy in Patients Fulfilling ROME IV Criteria of Irritable Bowel Syndrome
por: Paudel, Mukesh Sharma, et al.
Publicado: (2018)

Pros and Cons While Looking Through an Asian Window on the Rome IV Criteria for Irritable Bowel Syndrome: Pros
por: Ghoshal, Uday C
Publicado: (2017)

Validity and Reliability of the Japanese Version of the Rome III Diagnostic Questionnaire for Irritable Bowel Syndrome and Functional Dyspepsia
por: Kanazawa, Motoyori, et al.
Publicado: (2015)

Diagnosis of functional constipation: Agreement between Rome III and Rome II criteria and evaluation for the practicality
por: Xin, Hai Wei, et al.
Publicado: (2014)

Awareness and Utilization of ROME Criteria for Diagnosis of Irritable Bowel Syndrome among Primary Care Physicians in Riyadh, Saudi Arabia
por: Al-Shamrani, Hamoud Abdul Aziz, et al.
Publicado: (2020)

Sensitivity and specificity of mean platelet volume as a laboratory marker for irritable bowel syndrome: Can it be added to Rome criteria?
por: Vaghari-Tabari, Mostafa, et al.
Publicado: (2020)

Irritable Bowel Syndrome Prevalence among Participants of Woodstock Rock Festival in Poland Based on Rome IV Criteria Questionnaire
por: Palma, Joanna, et al.
Publicado: (2021)

Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life
por: Ozer, Muhammet, et al.
Publicado: (2020)

Probiotics and irritable bowel syndrome
por: Korpela, Riitta, et al.
Publicado: (2012)

Relationship between overactive bladder and irritable bowel syndrome: a large-scale internet survey in Japan using the overactive bladder symptom score and Rome III criteria
por: Matsumoto, Seiji, et al.
Publicado: (2013)

The prevalence of irritable bowel syndrome among Saudi population in Riyadh by use of Rome IV criteria and self-reported dietary restriction
por: Amin, Hussein S., et al.
Publicado: (2021)

Functional gastrointestinal disorders in children: agreement between Rome III and Rome IV diagnoses
por: Baaleman, Desiree F., et al.
Publicado: (2021)

Understanding the Changes in Diagnostic Criteria for Functional Constipation in Pediatric Patients: From Rome III to Rome IV
por: Lee, Yoo Jin, et al.
Publicado: (2019)

Impact of Rome IV irritable bowel syndrome on work and activities of daily living
por: Goodoory, Vivek C., et al.
Publicado: (2022)

Willingness to pay for medications among patients with Rome IV Irritable Bowel Syndrome
por: Goodoory, Vivek C., et al.
Publicado: (2022)

Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials
por: Qi, Qingqing, et al.
Publicado: (2018)

Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
por: Fang, Yu-Jen, et al.
Publicado: (2015)

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
por: Tornkvist, Navkiran T., et al.
Publicado: (2021)

Does propolis affect the quality of life and complications in subjects with irritable bowel syndrome (diagnosed with Rome IV criteria)? A study protocol of the randomized, double-blinded, placebo-controlled clinical trial
por: Miryan, Mahsa, et al.
Publicado: (2020)

Upper gastrointestinal endoscopic findings in functional constipation and irritable bowel syndrome diagnosed using the Rome IV criteria: a cross-sectional survey during a medical check-up in Japan
por: Otani, Koji, et al.
Publicado: (2023)

To Understand the Modulatory Effect of Probiotics on Irritable Bowel Syndrome
por: Yuan, Anlong, et al.
Publicado: (2018)

Are Food Constituents Relevant to the Irritable Bowel Syndrome in Young Adults? - A Rome III Based Prevalence Study of the Korean Medical Students
por: Jung, Hyun Joo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8scipva5aemkt9ljpgbm13j492